Budesonide Treatment for Lymphocytic Colitis

Technische Universität Dresden

Status and phase: Completed; Phase 3

Conditions: Microscopic Colitis

Treatments: Drug: Budesonide

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00180050

BLYCK

Details and patient eligibility

About

The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis

Full description

The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• lymphocytic colitis
• diarrhea
• effective contraception
• written informed consent

Exclusion criteria

• other forms if IBD
• celiac disease
• infectious colitis
• history of colonic surgery
• use of budesonide, 5-ASA, steroids within th previous 4 weeks
• pregnancy, lactation

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind